KENDAL JUSTICE: Open Payments
NPI 1427802966 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 107 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $928 · 2025 $1,917
Food & beverage: $1,917
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $386 |
| Neurocrine BioSciences, Inc. | 19 | $315 |
| Teva Pharmaceuticals USA, Inc. | 12 | $226 |
| Lundbeck LLC | 9 | $166 |
| E.R. Squibb & Sons, L.L.C. | 10 | $155 |
| Collegium Pharmaceutical, Inc. | 9 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
Products named: VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, COBENFY, AUSTEDO XR, Jornay PM, CAPLYTA, REXULTI.
Industry payments across IL — which companies pay providers there.
